The FASEB Journal,
Journal Year:
2024,
Volume and Issue:
38(11)
Published: June 7, 2024
Abstract
Tumor
hypoxia
has
been
associated
with
cancer
progression,
angiogenesis,
and
metastasis
via
modifications
in
the
release
cargo
composition
of
extracellular
vesicles
secreted
by
tumor
cells.
Indeed,
hypoxic
are
known
to
trigger
a
variety
angiogenic
responses
different
mechanisms.
We
recently
showed
that
promotes
endosomal
signaling
cells
HIF‐1α‐dependent
induction
guanine
exchange
factor
ALS2,
which
activates
Rab5,
leading
downstream
events
involved
cell
migration
invasion.
Since
Rab5‐dependent
is
required
for
endothelial
we
explored
possibility
small
containing
turn
activate
Rab5
recipient
pro‐angiogenic
properties.
In
doing
so,
found
promoted
ALS2
expression
incorporation
as
within
vesicles,
subsequent
transfer
promoting
migration,
tube
formation,
activation.
Consequently,
ALS2‐containing
increased
early
endosome
size
number
cells,
was
followed
sequestration
components
β‐catenin
destruction
complex
compartments,
stabilization
nuclear
localization
β‐catenin.
These
converged
target
genes
angiogenesis.
Knockdown
donor
precluded
its
into
preventing
Rab5‐downstream
responses,
depended
on
activity
ALS2.
findings
indicate
vesicular
hypoxia,
Finally,
these
might
explain
how
angiogenesis
proceeds
conditions.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 2, 2025
Protein
O-GlcNAcylation
is
a
post-translational
modification
coupled
to
cellular
metabolic
plasticity.
Aberrant
has
been
observed
in
many
cancers
including
endometrial
cancer
(EC),
common
malignancy
women.
However,
clinical
characterization
of
dysregulated
homeostasis
EC
and
interrogating
its
molecular
mechanism
remain
incomplete.
Here
we
report
that
level
positively
correlated
with
histologic
grade
Chinese
cohort
containing
219
tumors,
validated
The
Cancer
Genome
Atlas
dataset.
Increasing
patient-derived
epithelial
organoids
promotes
proliferation
stem-like
cell
properties,
whereas
decreasing
limits
the
growth
organoids.
CRISPR
screen
biochemical
reveal
tumor
suppressor
F-box
only
protein
31
(FBXO31)
regulates
by
ubiquitinating
O-GlcNAc
transferase
OGT.
Downregulation
impedes
formation
mouse
models.
Collectively,
our
study
highlights
as
useful
stratification
marker
therapeutic
vulnerability
for
advanced,
poorly
differentiated
cases.
linked
(EC).
authors
grade,
FBXO31
Frontiers in Oncology,
Journal Year:
2023,
Volume and Issue:
13
Published: March 21, 2023
Background
Bladder
cancer
(BC)
is
a
disease
with
significant
heterogeneity
and
poor
prognosis.
The
prognosis
therapeutic
response
of
BC
patients
are
significantly
influenced
by
endothelial
cells
in
the
tumor
microenvironment.
In
order
to
understand
from
perspective
cells,
we
orchestrated
molecular
subtypes
identified
key
genes.
Methods
Single-cell
bulk
RNA
sequencing
data
were
extracted
online
databases.
R
its
relative
packages
used
analyze
these
data.
Cluster
analysis,
prognostic
value
function
immune
checkpoints,
environment
prediction
conducted.
Results
Five
endothelial-related
genes
(CYTL1,
FAM43A,
HSPG2,
RBP7,
TCF4)
divided
TCGA,
GSE13507,
GSE32894
datasets
into
two
clusters,
respectively.
cluster
2
substantially
associated
worse
overall
survival
than
those
1
according
results
GSE13507
datasets.
functional
clusters
was
enriched
immune-related,
metabolism-related
pathways.
Samples
had
statistically
increase
CD4+
T
NK-cell
infiltration.
positively
correlated
stem
score
mutational
burden
score.
analysis
indicated
that
50.6%
(119/235)
responded
immunotherapy,
while
rate
decreased
16.7%
(26/155).
Conclusion
this
study,
categorized
discovered
distinctive
prognosis-related
at
genetic
level
integrating
single-cell
data,
primarily
provide
roadmap
for
precision
medicine.
MedComm,
Journal Year:
2025,
Volume and Issue:
6(3)
Published: Feb. 21, 2025
Abstract
The
integration
of
liquid
biopsy
with
epigenetic
markers
offers
significant
potential
for
early
lung
cancer
detection
and
personalized
treatment.
Epigenetic
alterations,
including
DNA
methylation,
histone
modifications,
noncoding
RNA
changes,
often
precede
genetic
mutations
are
critical
in
progression.
In
this
study,
we
explore
how
biopsy,
combined
markers,
can
provide
cancer,
potentially
predicting
onset
up
to
4
years
before
clinical
diagnosis.
We
discuss
the
challenges
targeting
regulators,
which
could
disrupt
cellular
balance
if
overexploited,
need
maintaining
key
gene
expressions
therapeutic
applications.
This
review
highlights
promise
using
early‐stage
diagnosis,
a
focus
on
optimizing
treatment
strategies
precision
medicine.
Advanced Science,
Journal Year:
2022,
Volume and Issue:
9(30)
Published: Aug. 31, 2022
Abstract
A
malformed
tumour
vascular
network
provokes
the
nutrient‐deprived
microenvironment
(TME),
which
conversely
activates
endothelial
cell
(EC)
functions
and
stimulates
neovascularization.
Emerging
evidence
suggests
that
flexible
metabolic
adaptability
of
cells
helps
to
establish
a
symbiosis
among
various
subpopulations
in
fluctuating
TME.
In
this
study,
authors
propose
novel
link
between
bladder
cancer
(BCa)
ECs
nutrient‐scarce
TME,
BCa‐secreted
glutamine‐fructose‐6‐phosphate
aminotransferase
1
(GFAT1)
via
small
extracellular
vesicles
(sEVs)
reprograms
glucose
metabolism
by
increasing
hexosamine
biosynthesis
pathway
flux
thus
enhances
O‐GlcNAcylation.
Moreover,
seryl‐tRNA
synthetase
(SerRS)
O‐GlcNAcylation
at
serine
101
promotes
its
degradation
ubiquitination
impeded
importin
α
5‐mediated
nuclear
translocation.
Intranuclear
SerRS
attenuates
growth
factor
transcription
competitively
binding
GC‐rich
region
proximal
promotor.
Additionally,
GFAT1
knockout
blocks
angiogenesis
both
vitro
vivo.
However,
administration
GFAT1‐overexpressing
BCa
cells‐derived
sEVs
increase
angiogenetic
activity
GFAT1‐knockout
mice.
summary,
study
inhibiting
sEV‐mediated
secretion
from
targeting
may
serve
as
strategies
for
antiangiogenetic
therapy.
Cancer Biology & Therapy,
Journal Year:
2024,
Volume and Issue:
25(1)
Published: May 20, 2024
The
tumor
microenvironment
(TME)
plays
an
essential
role
in
cell
survival
by
profoundly
influencing
their
proliferation,
metastasis,
immune
evasion,
and
resistance
to
treatment.
Extracellular
vesicles
(EVs)
are
small
particles
released
all
types
often
reflect
the
state
of
parental
cells
modulate
other
cells'
functions
through
various
cargo
they
transport.
Tumor-derived
EVs
(TDSEVs)
can
transport
specific
proteins,
nucleic
acids
lipids
tailored
propagate
signals
establish
a
favorable
TME.
Thus,
TME's
biological
characteristics
affect
TDSEV
heterogeneity,
this
interplay
amplify
growth,
dissemination,
therapy.
This
review
discusses
between
TME
TDSEVs
based
on
summarizes
strategies
for
targeting
cancer
cells.
Additionally,
it
reviews
current
issues
challenges
field
offer
fresh
insights
into
comprehending
development
mechanisms
exploring
innovative
clinical
applications.
Clinical and Translational Medicine,
Journal Year:
2024,
Volume and Issue:
14(11)
Published: Oct. 25, 2024
Lactylation,
a
recently
identified
form
of
protein
post-translational
modification
(PTM),
has
emerged
as
key
player
in
cancer
biology.
The
Warburg
effect,
hallmark
tumour
metabolism,
underscores
the
significance
lactylation
progression.
By
regulating
gene
transcription
and
function,
facilitates
metabolic
reprogramming,
enabling
tumours
to
adapt
nutrient
limitations
sustain
rapid
growth.
Over
past
decade,
extensive
research
revealed
intricate
regulatory
network
underlying
tumours.
Large-scale
sequencing
machine
learning
have
confirmed
widespread
occurrence
sites
across
proteome.
Targeting
enzymes
or
pathways
demonstrated
promising
anti-tumour
effects,
highlighting
therapeutic
potential
this
modification.
This
review
comprehensively
explores
mechanisms
cells
microenvironment.
We
expound
on
application
advanced
omics
technologies
for
target
identification
data
modelling
within
field.
Additionally,
we
summarise
existing
anti-lactylation
drugs
discuss
their
clinical
implications.
providing
comprehensive
overview
recent
advancements,
aims
stimulate
innovative
accelerate
translation
lactylation-based
therapies
into
practice.
KEY
POINTS:
Lactylation
significantly
influences
metabolism
regulation,
contributing
Advanced
reveal
shows
promise
enhancing
drug
efficacy
overcoming
chemotherapy
resistance.
outlines
implications
future
directions
oncology.